Acutaas Chemicals Q4 PAT Soars 114% YoY to ₹1,343mn

Acutaas Chemicals reported Q4 FY26 revenue growth of 40.3% YoY to ₹4,328mn with PAT surging 114.1% to ₹1,343mn.
Margins expanded significantly with gross margin at 62.0% (up 1,470 bps YoY) and PAT margin at 31.0% (up 1,070 bps YoY).
The company outlined a three-vertical growth strategy focusing on Battery Chemicals, Semiconductors, and Pharmaceutical CDMO segments.
Management provided FY27 revenue growth guidance of 25% from a position of strength.